THE IMMUNOLOGICAL HYPORESPONSIVENESS AND DONOR CELL PERSISTENCE IN HOST LIVER AFER PORTAL VENOUS INNOCULATION
THE IMMUNOLOGICAL HYPORESPONSIVENESS AND DONOR CELL PERSISTENCE IN HOST LIVER AFER PORTAL VENOUS INNOCULATION
批准号:
06671205
负责人:
TANAKA Noriaki
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
immunosuppressants used now a days in transplantation have only incomplete inhibition of Therejection but also some incidense of complications such as oppotunistic infection,malignansies etc. hypo- or no response to the antigen is called immunological tolerance这是一个比较低或没有影响的免疫反应和反应。Although portal venous inoculation of donor antigen was reported to induce donor-specifichyporesponsiveness and prolongation of the grafts in animal modelsthe mechanism of the portal tolerance has not been clearly understood. In this study,we investigated the corelation between donor cell persistence in host liver and the suppression ofdonor-specific mixed lymphocyte reaction. The sequential changes in fluoresence labeled donor cellsinoculated via the portal (PV group) or peripheral (IV group) vein were examined using fluoresencemicroscopy and flow cytometory. The fluorescent positive cells mainly located i…n the sinusoid of periportal and midzonal area of hepatic lobulesand several and a few positive cells per hepatic lobules on day 3 and 7The number of fluoresent positive cells was seen impresively greater in PV group thanin IV group on day 3 and 7. More quantitatively,flow cytometric analysis of the isolated hepatic non-parenchymal cells revealed that the centagefluoresent positive cells were significantly higher in PV group than in IV group on day 3but no significant difference could not be observed between both groups on day 7. MLR wassignificantly suppressed on day 3 and slightly on day 7 in PV group,comparing with slight MLR suppression only on day 3 in IV group. Gadolinium chloride (Gd) whichinhibits the phagocytic activity of Kupffer cell was given intravenously to host rats on 2consecutive days before portal venous inoculation (GdPV group). In GdPV group high percentage ofdonor cell persistence and the suppression of MLR by portal venous inoculation were lost to the lowlevel of IV group on day 3. Oral tolerancewhich induces the suppression of anbibody production and cellular immunity in an antigen specificfashion,was studied to be able to apply to the transplantation tolerance. Intra-jejunal administration ofdonor spleen cells (5×10 /day×5days) through the jejunostomy tube was proud to suppress theMLR和foot pad reaction in a donor specific mannerand significantly prolonge the cardiac allograft survival. Gd administration lost thesedonor-specific immunological hyporesponsiveness and the prolongation of gaft survival. These resultsindicates high percentage of persistent donor cells in the host liver was good corelation withthe suppression in donor-specific MLR and Kupffer cells play a crucial role in the portal而且. less
英文摘要
The immunosuppressants used now a days in transplantation have not only incomplete inhibition of the rejection but also some incidense of complications such as oppotunistic infection, malignansies etc. hypo- or no response to the antigen is called immunological tolerance, which induces low or no incidense of rejection and results from the reduction of immunosuppressants. Although portal venous inoculation of donor antigen was reported to induce donor-specific hyporesponsiveness and prolongation of the grafts in animal models, the mechanism of the portal tolerance has not been clearly understood. In this study, we investigated the corelation between donor cell persistence in host liver and the suppression of donor-specific mixed lymphocyte reaction. The sequential changes in fluoresence labeled donor cells inoculated via the portal (PV group) or peripheral (IV group) vein were examined using fluoresence microscopy and flow cytometory. The fluorescent positive cells were mainly located i … More n the sinusoid of periportal and midzonal area of hepatic lobules, and several and a few positive cells per hepatic lobules on day 3 and 7, respectively. The number of fluoresent positive cells was seen impresively greater in PV group than in IV group on day 3 and 7. More quantitatively, flow cytometric analysis of the isolated hepatic non-parenchymal cells revealed that the percentage of fluoresent positive cells were significantly higher in PV group than in IV group on day 3, but no significant difference could not be observed between both groups on day 7. MLR was significantly suppressed on day 3 and slightly on day 7 in PV group, comparing with slight MLR suppression only on day 3 in IV group. Gadolinium chloride (Gd) which inhibits the phagocytic activity of Kupffer cell was given intravenously to host rats on 2 consecutive days before portal venous inoculation (GdPV group). In GdPV group high percentage of donor cell persistence and the suppression of MLR by portal venous inoculation were lost to the low level of IV group on day 3. Oral tolerance, which induces the suppression of anbibody production and cellular immunity in an antigen specific fashion, was studied to be able to apply to the transplantation tolerance. Intra-jejunal administration of donor spleen cells (5×10ィイD17ィエD1/day×5days) through the jejunostomy tube was proud to suppress the MLR and foot pad reaction in a donor specific manner, and significantly prolonge the cardiac allograft survival. Gd administration lost these donor-specific immunological hyporesponsiveness and the prolongation of gaft survival. These results indicates that high percentage of persistent donor cells in the host liver was good corelation with the suppression in donor-specific MLR and Kupffer cells play a crucial role in the portal tolerance. Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Isido, N., Matsuoka J., Nakagawa, K., Matsumoto, T., and Tanaka, N.,: "Induction of hyporesponsiveness and prolongation of cardiac allograft survival after jejunal administration of donor splenocytes and its abrogation by administration of gadolinium."Tra
Isido, N.、Matsuoka J.、Nakakawa, K.、Matsumoto, T. 和 Tanaka, N.:“空肠给予供体脾细胞后诱导低反应性并延长心脏同种异体移植物的存活率,并通过给予钆消除这种情况。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishido, N., Matsumoto, T., Matsuoka, J., Nakagawa, K., Haisa, M., Saito, S., Yagi, T., Oishi, M., Ishikawa, T., Fujisawa, K., Matsuda, H., Okada, Y., Endo, A., and Tanaka, N.,: "Can intraoperative inoculation of donor splenocytes via the portal vein prolo
石户,N.,松本,T.,松冈,J.,中川,K.,Haisa,M.,斋藤,S.,八木,T.,大石,M.,石川,T.,藤泽,K.,
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishido,N.: "Can intraoperative inoculation of donor splenocytes via the portal vein prolong allograft survival?"Transplantation Proceedings. 30. 3883-3884 (1998)
Ishido,N.:“术中通过门静脉接种供体脾细胞可以延长同种异体移植物的存活吗?”移植论文集。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Uda, M., Fujiwara, T., Kusaka, S., Matsumoto, T., Tanaka, N., and Orita, K.,: "Donor specific inhibitory factor induced by portal venous inoculation with ultraviolet-B irradiated spleen cells in nonhuman primates."Transplantation Proceedings.. 26. 1848-18
Uda, M.、Fujiwara, T.、Kusaka, S.、Matsumoto, T.、Tanaka, N. 和 Orita, K.:“门静脉接种紫外线 B 照射的脾细胞诱导的供体特异性抑制因子
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Uda,M.: "Donor specific inhibitory factor induced by portal venous inoculation with ultraviolet-B irradiated spleen cells in nonhuman primates"Transplantation Proceedings. 26. 1848-1850 (1994)
Uda,M.:“在非人类灵长类动物中用紫外线 B 照射的脾细胞门静脉接种诱导的供体特异性抑制因子”移植论文集。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
総合ビタミン製剤の連続投与が高度腎機能障害患者に及ぼす影響の解明
-
批准号:19H00350
-
项目类别:Grant-in-Aid for Encouragement of Scientists
-
资助金额:$0.35万
-
财政年份:2019
-
负责人:TANAKA Noriaki
-
依托单位:
Contribution of chemokines and growth factors for the cervical lymph node metastasis in oral squamous cell carcinoma
-
批准号:24792206
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2012
-
负责人:TANAKA Noriaki
-
依托单位:
The relationship of MMPs and growth factors in the invasion mechanism of adenoid cystic carcinoma
-
批准号:20791561
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2008
-
负责人:TANAKA Noriaki
-
依托单位:
Hepatic differentiation of human embryonic stem cells and its application to the development of a bioartificial liver system
-
批准号:19390334
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2007
-
负责人:TANAKA Noriaki
-
依托单位:
Elucidation, of the interacting mechanism between epigenetic and genetic alterations in gastrointestinal cancers and of the possible application to the clinic
-
批准号:17390368
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.92万
-
财政年份:2005
-
负责人:TANAKA Noriaki
-
依托单位:
Development of Regenerative Medicine Using Reversibly Proliferating Human Bone Marrow Mesenchymal Stem Cells
-
批准号:15390378
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2003
-
负责人:TANAKA Noriaki
-
依托单位:
Bioartificial liver development using reversibly immortalized human liver cell lines.
-
批准号:13470236
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.56万
-
财政年份:2001
-
负责人:TANAKA Noriaki
-
依托单位:
Cell cycle transactivation factor E2F-4 is associate with the ganstrointestinal carcinogenesis and/or acquisition of chemoresistance
-
批准号:11671237
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TANAKA Noriaki
-
依托单位:
Role of ornithine decarboxylase (ODC) as a oncogene in colorectal tumorigenesis
-
批准号:08671368
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.45万
-
财政年份:1996
-
负责人:TANAKA Noriaki
-
依托单位:
Studies on the functions of the actirated lymphocytes after partial hepatectomy
-
批准号:60480293
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.24万
-
财政年份:1985
-
负责人:TANAKA Noriaki
-
依托单位:
国内基金
海外基金
Consequences of MALT1 mutation for B cell tolerance
-
批准号:32100719
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:James Qun Wang
-
依托单位: